Search PubMed⌕ Search

Biomedical subjects

Marc Häder

Publications and source records attributed to Marc Häder.

2 recordsLinked to original sources

Epileptogenic drugs in a model nervous system: electrophysiological effects and incorporation into a phospholipid layer.

Mechanisms of epileptiform activity in a model nervous system (buccal ganglia of Helix pomatia) are presented. The ganglia contain the identified giant neurons B1 through B4. For epileptiform activity, pentylenetetrazol (1 mmol/L to 40 mmol/L) or etomidate (12.5 micromol/L to 500 micromol/L) were applied. Membrane pressure was measured using a Wilhelmy film balance. In electrophysiological experiments, both drugs induced several effects in all studied neurons: membrane resistance increased, down-stroke of action potentials declined, and all types of chemical synaptic potentials decreased (the latter concerns pentylenetetrazol only). The threshold was 1 mmol/L of pentylenetetrazol and 12.5 micromol/L of etomidate. Epileptiform potentials developed in neurons that had expressed the membrane mechanisms underlying pacemaker potentials. The threshold of this development was again 1 mmol/L of pentylenetetrazol and 12.5 micromol/L of etomidate. Epileptiform depolarizations appeared with 40 mmol/L of pentylenetetrazol and 500 micromol/L of etomidate. In biochemical experiments, both drugs incorporated into an artificial phospholipids membrane and increased pressure in the membrane. The threshold of pressure increase was 1 mmol/L of pentylenetetrazol and 12.5 micromol/L of etomidate. Pressure increased dose-dependently and was 69% and 63% above starting pressure of 10 mN/m with epileptogenic concentrations of pentylenetetrazol (40 mmol/L) and of etomidate (500 micromol/L), respectively. It is postulated that amphiphilic substances incorporate into cell membranes and increase intramembranous pressure, and that this disturbs several membrane processes mechanically and leads to epileptic depolarizations in pacemaker neurons.

Action Potentials↗

Endogenous pacemaker potentials develop into paroxysmal depolarization shifts (PDSs) with application of an epileptogenic drug.

Well-known invertebrate ganglia (buccal ganglia of Helix pomatia, abdominal ganglia of Aplysia californica) were used to study the contribution of synaptic potentials, central pattern generators, and endogenously generated neuronal potentials to the development of epileptiform activity. Epileptiform activity which was induced with application of pentylenetetrazol (1 to 100 mM) or etomidate (0.12 to 1.0 mM) consisted of paroxysmal depolarization shifts (PDSs) recorded simultaneously from several identified neurons with sharp microelectrodes. With application of an epileptogenic drug, endogenous pacemaker potentials develop into PDSs. With increasing concentration of the drug, (i) amplitude of pacemaker-depolarizations and (ii) delay of pacemaker-repolarization increased progressively finally resulting in PDSs. Additionally, the activation characterists of currents shifted from between -50 and -40 mV (pacemaker potentials, control conditions) to between -100 and -40 mV (PDS, epileptic conditions). Only neurons which generated pacemaker potentials under control conditions could generate PDSs under epileptic conditions. Chemical synaptic inputs triggered or blocked pacemaker potentials as well as PDSs. Activities induced from central pattern generators were identified with simultaneous recordings from several identified neurons. The central pattern generators could trigger or block pacemaker potentials as well as PDSs. Results demonstrate that, in the used model nervous systems, pacemaker potentials which are generated by the single neurons are the physiologic basis of epileptic activity.

Animals↗